[1]

Arnold M, Park JY, Camargo MC, Lunet N, Forman D, et al. 2020. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut 69:823−29

doi: 10.1136/gutjnl-2019-320234
[2]

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, et al. 2024. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 74:229−63

doi: 10.3322/caac.21834
[3]

Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. 2020. Gastric cancer. The Lancet 396:635−48

doi: 10.1016/S0140-6736(20)31288-5
[4]

Xin J, Deng C, Aras O, Zhou M, Wu C, et al. 2021. Chemodynamic nanomaterials for cancer theranostics. Journal of Nanobiotechnology 19:192

doi: 10.1186/s12951-021-00936-y
[5]

Frei T, Cella F, Tedeschi F, Gutiérrez J, Stan GB, et al. 2020. Characterization and mitigation of gene expression burden in mammalian cells. Nature Communications 11:4641

doi: 10.1038/s41467-020-18392-x
[6]

Fang W, Bartel DP. 2020. microRNA clustering assists processing of suboptimal microRNA hairpins through the action of the ERH protein. Molecular Cell 78:289−302.e6

doi: 10.1016/j.molcel.2020.01.026
[7]

Guo T, Tang XH, Gao XY, Zhou Y, Jin B, et al. 2022. A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer. Molecular Cancer 21:216

doi: 10.1186/s12943-022-01684-9
[8]

Zhang Q, Deng T, Zhang H, Zuo D, Zhu Q, et al. 2022. Adipocyte-derived exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer. Advanced Science 9:2203357

doi: 10.1002/advs.202203357
[9]

Jin J, Xie Y, Zhang JS, Wang JQ, Dai SJ, et al. 2023. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Resistance Updates 67:100929

doi: 10.1016/j.drup.2023.100929
[10]

Li K, Chen Y, Li A, Tan C, Liu X. 2019. Exosomes play roles in sequential processes of tumor metastasis. International Journal of Cancer 144:1486−95

doi: 10.1002/ijc.31774
[11]

Jiang W, Mei WJ, Xu SY, Ling YH, Li WR, et al. 2022. Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learning. eBioMedicine 81:104120

doi: 10.1016/j.ebiom.2022.104120
[12]

Chen C, Wang J, Pan D, Wang X, Xu Y, et al. 2023. Applications of multi-omics analysis in human diseases. MedComm(2020) 4:e315

doi: 10.1002/mco2.315
[13]

Ye Z, Yi J, Jiang X, Shi W, Xu H, et al. 2025. Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression. Journal of Experimental & Clinical Cancer Research 44:2

doi: 10.1186/s13046-024-03269-4
[14]

Piccinno E, Schirizzi A, Scalavino V, De Leonardis G, Donghia R, et al. 2024. Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as novel predictive biomarkers for ramucirumab–paclitaxel therapy outcomes in advanced gastric cancer. International Journal of Molecular Sciences 25:13498

doi: 10.3390/ijms252413498
[15]

Wang Z, Li Y, Cao J, Zhang W, Wang Q, et al. 2020. microRNA profile identifies miR-6165 could suppress gastric cancer migration and invasion by targeting STRN4. OncoTargets and Therapy 13:1859−69

doi: 10.2147/OTT.S208024
[16]

Zhang J, Yu D, Ji C, Wang M, Fu M, et al. 2024. Exosomal miR-4745-5p/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2. Molecular Cancer 23:198

doi: 10.1186/s12943-024-02116-6
[17]

Zhang Z, Pi J, Zou D, Wang X, Xu J, et al. 2019. microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression. Nature Communications 10:4397

doi: 10.1038/s41467-019-12292-5
[18]

Stevens MT, Saunders BM. 2021. Targets and regulation of microRNA-652-3p in homoeostasis and disease. Journal of Molecular Medicine 99:755−69

doi: 10.1007/s00109-021-02060-8
[19]

Liu R, Zhang C, Hu Z, Li G, Wang C, et al. 2011. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. European Journal of Cancer 47:784−91

doi: 10.1016/j.ejca.2010.10.025
[20]

Shin VY, Ng EKO, Chan VW, Kwong A, Chu KM. 2015. A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer. Molecular Cancer 14:202

doi: 10.1186/s12943-015-0473-3
[21]

Higashijima Y, Kanki Y. 2020. Molecular mechanistic insights: The emerging role of SOXF transcription factors in tumorigenesis and development. Seminars in Cancer Biology 67:39−48

doi: 10.1016/j.semcancer.2019.09.008
[22]

Li YZ, Mou P, Shen Y, Gao LD, Chen XX, et al. 2022. Effect of miR-184 and miR-205 on the tumorigenesis of conjunctival mucosa associated lymphoid tissue lymphoma through regulating RasL10B and TNFAIP8. International Journal of Ophthalmology 15:1−8

doi: 10.18240/ijo.2022.01.01
[23]

Feng R, Dong L. 2015. Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in vitro. International Journal of Clinical and Experimental Pathology 8:9376−82
[24]

Park JK, Peng H, Yang W, Katsnelson J, Volpert O, et al. 2017. miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways. FASEB Journal 31:256−65

doi: 10.1096/fj.201600746r
[25]

Abdelbaky I, Tayara H, Chong KT. 2022. Identification of miRNA-small molecule associations by continuous feature representation using auto-encoders. Pharmaceutics 14:3

doi: 10.3390/pharmaceutics14010003
[26]

Hashimoto Y, Akiyama Y, Yuasa Y. 2013. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One 8:e62589

doi: 10.1371/journal.pone.0062589
[27]

Guo J, Miao Y, Xiao B, Huan R, Jiang Z, et al. 2009. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. Journal of Gastroenterology and Hepatology 24:652−57

doi: 10.1111/j.1440-1746.2008.05666.x
[28]

Hu H, Quan G, Yang F, Du S, Ding S, et al. 2023. microRNA-96-5p is negatively regulating GPC3 in the metastasis of papillary thyroid cancer. SAGE Open Medicine 11:20503121231205710

doi: 10.1177/20503121231205710
[29]

Wang B, Liu X, Meng X. 2020. miR-96-5p enhances cell proliferation and invasion via targeted regulation of ZDHHC5 in gastric cancer. Bioscience Reports 40:BSR20191845

doi: 10.1042/BSR20191845
[30]

Zhang C, Zhang CD, Liang Y, Wu KZ, Pei JP, et al. 2020. The comprehensive upstream transcription and downstream targeting regulation network of miRNAs reveal potential diagnostic roles in gastric cancer. Life Sciences 253:117741

doi: 10.1016/j.lfs.2020.117741
[31]

Zhang H, Du Y, Xin P, Man X. 2022. The LINC00852/miR-29a-3p/JARID2 axis regulates the proliferation and invasion of prostate cancer cell. BMC Cancer 22:1269

doi: 10.1186/s12885-022-10263-6
[32]

Miyake M, Hori S, Morizawa Y, Tatsumi Y, Toritsuka M, et al. 2017. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder. Oncotarget 8:36099−114

doi: 10.18632/oncotarget.16432
[33]

Kim HY, Kim YM, Hong S. 2019. Astaxanthin suppresses the metastasis of colon cancer by inhibiting the MYC-mediated downregulation of microRNA-29a-3p and microRNA-200a. Scientific Reports 9:9457

doi: 10.1038/s41598-019-45924-3
[34]

Xiao Y, Yang P, Xiao W, Yu Z, Li J, et al. 2025. POU2F1 inhibits miR-29b1/a cluster-mediated suppression of PIK3R1 and PIK3R3 expression to regulate gastric cancer cell invasion and migration. Chinese Medical Journal 138:838−50

doi: 10.1097/CM9.0000000000003181
[35]

Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R. 2022. miRNA: a promising therapeutic target in cancer. International Journal of Molecular Sciences 23:11502

doi: 10.3390/ijms231911502
[36]

Xu W, Lu M, Xie S, Zhou D, Zhu M, et al. 2023. Endoplasmic reticulum stress promotes prostate cancer cells to release exosome and up-regulate PD-L1 expression via PI3K/Akt signaling pathway in macrophages. Journal of Cancer 14:1062−74

doi: 10.7150/jca.81933
[37]

Liu CY, Zhao WL, Wang JX, Zhao XF. 2015. Cyclin-dependent kinase regulatory subunit 1 promotes cell proliferation by insulin regulation. Cell Cycle 14:3045−57

doi: 10.1080/15384101.2015.1053664
[38]

Gu J, Han T, Sun L, Yan AH, Jiang XJ. 2020. miR-552 promotes laryngocarcinoma cells proliferation and metastasis by targeting p53 pathway. Cell Cycle 19:1012−21

doi: 10.1080/15384101.2020.1743910